CYGS to Fund InGene Expansion.HOUSTON--(BUSINESS WIRE)--Nov. 3, 1998--Cryogenic Solutions Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:CYGS) has agreed to fund the expansion of InGene Inc. to accommodate demand for ssDNA expression vector research. CYGS has revised the initial shipping date of the research kits to early 1999 as a result of the InGene expansion. The research kit is designed to demonstrate the various applications of the company's ssDNA expression vector technology. The kit is not intended to produce revenue and is for research purposes only. "We're convinced this technology can enable a broad spectrum of genetic research and therapies and the requests we have received for research kits corroborate To support or enhance the believability of a fact or assertion by the presentation of additional information that confirms the truthfulness of the item. The testimony of a witness is corroborated if subsequent evidence, such as a coroner's report or the testimony of other this position." said Dell Gibson. "The diversity of proposed studies using our product and the reputations of the researchers is also gratifying grat·i·fy tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies 1. To please or satisfy: His achievement gratified his father. See Synonyms at please. 2. ." The proprietary ssDNA expression vector synthesizes sequence specific, antisense antisense, DNA or RNA manipulated in a laboratory so that its components (nucleotides) form a complementary copy of normal, or "sense," messenger RNA (mRNA; see nucleic acid). competent oligodeoxyribonucleotides in vivo. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion